MSB 0.76% $1.31 mesoblast limited

Benelong..its a relevant issue because at start of week 13 the...

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    Benelong..its a relevant issue because at start of week 13 the Placebo patients started receiving a number of Biologic Anti-TNF Agents - all the way to week 39 to help the patient manage the disease....

    ...yet the MPC treated patients only had 1 SINGLE injection in the 1st week...yet outperformed Placebo at week 39.
    and without having the risk of side effects - which unfortunately some of the Placebo patients b/w weeks 13 -39 may be subjected to as a result of the continuous use of  Anti-TNF Agents to keep comfortable and less pain.

    You can understand why SI ( a rheumatologist himself) is so bloody excited ! So shoulf all MSB holders , stakeholders
    and  the very ill refractory RA patients

    This is my understanding and perspective.

    Have a great week.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.31
Change
-0.010(0.76%)
Mkt cap ! $1.495B
Open High Low Value Volume
$1.31 $1.33 $1.28 $1.819M 1.396M

Buyers (Bids)

No. Vol. Price($)
2 29972 $1.31
 

Sellers (Offers)

Price($) Vol. No.
$1.31 2008 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.